KPV vs BPC-157: Mechanism, Specs & Reported Ranges Compared
Side-by-side comparison of KPV and BPC-157 — receptor mechanism, half-life, vial sizes, reconstitution and reported study arms.
By PX1 Research Team · August 4, 2026
KPV vs BPC-157 at a glance
| KPV | BPC-157 | |
|---|---|---|
| Class | C-terminal tripeptide of α-MSH | synthetic pentadecapeptide derived from gastric juice protein BPC |
| Reported half-life | not well characterized | short (minutes in plasma) |
| Vial sizes | 10 mg | 5 mg / 10 mg |
| Typical reconstitution | 10 mg + 2 mL = 5 mg/mL | 5 mg + 2 mL = 2.5 mg/mL (250 mcg = 10 units) |
| Research focus | inflammatory-signalling and mucosal research | tissue-repair and gastrointestinal models |
Mechanistic difference
KPV is the C-terminal tripeptide of α-MSH studied in inflammatory-signalling models; BPC-157 is studied in tissue-repair models. Gut-focused research frequently uses both.
Reported study ranges side by side
KPV
| Study arm | Reported amount | Cadence |
|---|---|---|
| Low arm | 200 mcg | daily |
| Mid arm | 500 mcg | daily |
BPC-157
| Study arm | Reported amount | Cadence |
|---|---|---|
| Low arm | 200–250 mcg | daily |
| Mid arm | 500 mcg | daily |
| High arm | 500 mcg | twice daily |
Practical handling differences
Both arrive lyophilized and shelf-stable. KPV is typically prepared at 10 mg + 2 mL = 5 mg/mL; BPC-157 at 5 mg + 2 mL = 2.5 mg/mL (250 mcg = 10 units). Where half-lives differ, the literature's dosing cadence differs accordingly — longer-acting molecules are described weekly, shorter-acting ones daily or split.
Which one appears in which research context
KPV shows up primarily in inflammatory-signalling and mucosal research. BPC-157 is used in tissue-repair and gastrointestinal models. They are not interchangeable substitutes; the receptor profile, not the marketing category, determines where each is used.
Documentation and sourcing
Both are supplied at ≥99% HPLC purity with lot-level COAs at /coa. Product pages: KPV · BPC-157.
How PX1 documents every lot
Every PX1 lot ships with HPLC purity, LC-MS identity, residual solvent, moisture (Karl Fischer), sterility and endotoxin data. Lot documentation is published at /purity-reports, /endotoxin-reports and /coa. Synthesis, purification, lyophilization and vial fill happen in U.S. facilities — see /manufacturing-process.
Research use only. PX1 Research supplies compounds for laboratory and in-vitro research. Nothing here is medical advice, a dosing recommendation, or an offer for human or veterinary use. Figures cited are reported from published laboratory literature.